May 19, 2021 ProMIS Neurosciences appoints accomplished biotechnology executive, Neil Warma, to its Board of Directors
May 12, 2021 ProMIS Neurosciences appoints renowned neuroscientist, Dr. Rudolph Tanzi, as Chair of Scientific Advisory Board
Mar 22, 2021 ProMIS Neurosciences Completes US$7M (CDN$8.75M) Financing with Distinguished Group of Boston Based Investors
Feb 2, 2021 ProMIS Neurosciences Offers Perspectives on Recent Progress in the Alzheimer’s/Amyloid Field
Nov 9, 2020 ProMIS Neurosciences offers comments on recent FDA Advisory Committee meeting on aducanumab for the treatment of Alzheimer’s disease